(I) delay in publication of the 2026 annual results; (ii) possible delay in despatch of the 2026 annual report; and (iii) suspension of trading
Filed with HKEX · Stock code 660 ·
6ix hasn’t read this filing yet.
View original source (HKEXnews)Company analysis
Earlier from Wai Chun Bio-technology
- Wai Chun Bio Technology: RESIGNATION OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
- Wai Chun Bio Technology: APPOINTMENT OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
- Wai Chun Bio Technology: RESINGATION OF CHIEF FINANCIAL OFFICCER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
- Wai Chun Bio Technology: 2020 ANNUAL RESULTS ANNOUNCEMENT